Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia

Fig. 1

Deregulation of miR expression levels in a murine model of CMML. a To screen for aberrant miR expression profiles in CMML, we performed miR-microarray analysis in CD-11b/Ly-6G/c-Kit+ HSPCs isolated from the bone marrow of mice with a Ras-induced CMML-like MPD. Therefore, four Mx1-Cre+/KrasG12D mice and four KrasWt control mice were injected with pIpC as outlined in the materials and methods section. Mice were killed and analyzed 6 weeks later. The development of the CMML-like MPD at this time was verified as outlined in Additional file 1: Fig S13. b Volcano plot showing deregulated miRs in CMML-HSPCs of Mx1-Cre+/KrasG12D-mutated mice. The horizontal axis depicts the x-fold expression change in Mx1-Cre+/KrasG12D-mutated animals and transformed P-values are depicted on the vertical axis. miRs with higher expression in KrasG12D-mutated HSPCs are displayed on the right, whereas miRs with decreased expression levels in KrasG12D-mutated HSPCs are displayed on the left. cd qPCR validation of the miR microarray results shows decreased miR-125a, miR-150, and miR-26a expression in CD-11b/Ly-6G/c-Kit+ (c, n = 3) and Lin/Sca-1+/c-Kit+ (d, n = 4) HSPC compartments of Mx1-Cre+/KrasG12D mice. At least three mice per group were analyzed. The dot plots show the relative miR expression with the median indicated as horizontal line. One KrasWt mouse was always used as a calibrator and its expression is set to 1. Group differences were assessed by t test. Wt, wildtype;

Back to article page